drugset
Drugs / Autologous, lethally irradiated melanoma cells
last change Feb 2020 re-read 3 minutes ago

Autologous, lethally irradiated melanoma cells

Vaccine

Developed for
melanoma
Investigated by
Brigham and Women's Hospital · Dana-Farber Cancer Institute · Massachusetts General Hospital

Trials 1

today NCT00809588 · Ph 1
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00809588 Oct 2003 → Sep 2016 melanoma Dana-Farber Cancer Institute Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Autologous, lethally irradiated melanoma cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT00809588 ↗
Modality Vaccine “The vaccines created from the participants melanoma cells” NCT00809588 ↗
Route Subcutaneous “underneath the participants skin” NCT00809588 ↗